Gene therapy

Max L. Birnstiel

European Review, 1996, vol. 4, issue 4, 335-356

Abstract: Gene therapy makes use of cloned DNA molecules as pharmaceutical agents aimed at the treatment of both inherited genetic disease as well as acquired disorders such as cancer and viral infections. A major hurdle to be overcome in this approach is the introduction of genes into cells. Both viral and non-viral vectors have been used as ‘gene ferries’ and the design of vectors with desired specificities is under way. Today, the field has reached a stage where one can safely say that the principle of gene therapy has been proven and has been shown to represent a realistic therapy for patients, but much development is still required, especially in the area in in vivo gene transfer.

Date: 1996
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.cambridge.org/core/product/identifier/ ... type/journal_article link to article abstract page (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cup:eurrev:v:4:y:1996:i:04:p:335-356_00

Access Statistics for this article

More articles in European Review from Cambridge University Press Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().